Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: A two-institution study
Authors:
- E. JohanssonEJE. Johansson
- D. PapamichaelDPD. Papamichael
- F. CelsingFCF. Celsing
- J. MatthewsJMJ. Matthews
- T.A. ListerTLT.A. Lister
- A.Z.S. RohatinerARA.Z.S. Rohatiner
- 1 April 2003
- journal article
- research article
- Published by Elsevier in Seminars in Oncology
- Vol. 30 (2) , 226-230
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Waldenström MacroglobulinemiaAmerican Journal of Clinical Pathology, 2001
- Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)Blood, 2001
- Waldenström's MacroglobulinemiaThe Oncologist, 2000
- Waldenström’s Macroglobulinemia: Clinical Features, Complications, and ManagementJournal of Clinical Oncology, 2000
- Immunocytoma: A Retrospective Analysis From St Bartholomew's Hospital—1972 to 1996Journal of Clinical Oncology, 1999
- Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myelomaBlood, 1994
- Incidence of Waldenstrom's macroglobulinemiaBlood, 1993
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Incipient myelomatosis or «essential« hyperglobulinemia with fibrinogenopenia — a new syndrome?Acta Medica Scandinavica, 1944